Additional file 1 of Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer

Abstract

Additional file 1: Table S1. Risk differential analysis of all differentially expressed genes in high-risk and low-risk groups